About OASYS

While immunotherapy has transformed oncology, overcoming resistance in “cold” solid tumors remains a critical hurdle in cancer care. The OASYS group aims to address this challenge by identifying novel therapeutic associations and optimizing standard immunotherapy combinations. Our research focuses on how targeting specific oncogenic pathways and limiting tolerogenic soluble factors can modulate the tumor microenvironment to trigger effective immune responses.

To achieve these goals, the lab employs a highly translational approach, bridging molecular mechanism studies with advanced human ex vivo models, public dataset mining, and patient tumor samples. Utilizing cutting-edge technologies like spectral cytometry and scRNAseq, we finely map tumor evolution to discover predictive biomarkers and fuel early-phase clinical trials.

Through close integration with our academic, clinical, and industrial partners, our group is deeply committed to accelerating the journey from preclinical concept validation to clinical reality, ultimately striving to develop innovative immuno-oncology strategies that improve patient outcomes.

Science

>
Looking to develop and evaluate a new diagnostic compound using imaging ?
>
Need imaging to assess the biodistribution of your molecule ?
>
Aiming to generate and evaluate a novel targeted radionuclide therapy molecule ?

Discover our expertise from chemistry to biological evaluation for the development of your theranostic solution.

Latest news

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]

The IMATHERA team welcomes two new members

???? In February 2026, the IMATHERA team (preclinical imaging and radiotherapy lab) within the Department of Nuclear Medicine of the CGFL – Centre Georges-François Leclerc in Dijon is delighted to welcome two new members to its team : ???? Franz Goldet : Automated Quantification in Preclinical Nuclear Imaging Context (PhD[…]